BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10425190)

  • 1. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
    Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
    Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
    Brighty DW; Jassal SR
    J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells.
    Sagara Y; Inoue Y; Kojima E; Ishida C; Shiraki H; Maeda Y
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):125-35. PubMed ID: 11177392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
    Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
    J Virol; 1998 Jan; 72(1):535-41. PubMed ID: 9420256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
    Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
    Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
    Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
    Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
    Andrews JM; Oglesbee MJ; Trevino AV; Guyot DJ; Newbound GC; Lairmore MD
    Virology; 1995 Apr; 208(2):816-20. PubMed ID: 7747457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex.
    Sagara Y; Inoue Y; Kojima E; Shiraki H; Maeda Y
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1701-4. PubMed ID: 11080813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
    Nabeshi H; Yoshikawa T; Kamada H; Shibata H; Sugita T; Abe Y; Nagano K; Nomura T; Minowa K; Tsunoda S; Tsutsumi Y
    Pharmazie; 2010 Sep; 65(9):702-7. PubMed ID: 21038850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
    Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
    Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells.
    Paré ME; Gauthier S; Landry S; Sun J; Legault E; Leclerc D; Tanaka Y; Marriott SJ; Tremblay MJ; Barbeau B
    Virology; 2005 Aug; 338(2):309-22. PubMed ID: 15963547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
    Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
    Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
    Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
    J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
    Kuo CW; Mirsaliotis A; Brighty DW
    J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses.
    Iga M; Okayama A; Stuver S; Matsuoka M; Mueller N; Aoki M; Mitsuya H; Tachibana N; Tsubouchi H
    J Infect Dis; 2002 Mar; 185(5):691-5. PubMed ID: 11865428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.